A November 2 headline asks whether CON or Medpace Holdings offers better value. But the supplied information doesn’t identify CON, include its valuation figures, or say which stock the article favors.
Medpace’s latest supplied closing price was US$659.70, with a P/E of 36.2. Those figures describe Medpace alone and don’t show how it compares with CON.
Investor takeaway: The headline points to a value comparison, but without the underlying figures or conclusion, investors can assess only Medpace’s standalone data.
Medpace Holdings Inc
MEDP.US
MEDP.US
Medpace Holdings Inc
WealthAwesomeMarket cap
$18.24B
P/E
36.2x
52W high
$693.97
52W low
$373.00
1W change
-4.23%
Beta
1.18
Analyst Price Targets
Based on 14 analysts covering MEDP · as of Nov 2, 2026
Wall Street analysts forecast MEDP stock price to rise 0.5% over the next 12 months.
Consensus
Hold3.07 / 5.00
Avg. Target
C$651.31
+0.5% Upside
Previously C$644.77 on Oct 26, 2026
Current Price
C$648.14
Last close
Analyst Breakdown (14 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MEDP's historical volatility
30-Day Vol
34.2%
Annualized
90-Day Vol
36.7%
Annualized
Trend (90d)
+39.0%
Annualized drift
90d Mean
C$745.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$678.94 | C$603.35 – C$764.00 |
| 60 trading days | C$711.20 | C$601.87 – C$840.40 |
| 90 trading days | C$745.00 | C$607.25 – C$913.99 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Medpace’s P/E is 36.2
That’s a standalone valuation measure, not a comparison. The supplied information includes neither CON’s P/E nor the article’s assessment of which stock offers better value.
Bull case
Medpace reported an 18.2% profit margin and 117.9% return on equity. Its shares were up 13.51% year to date.
Bear case
The supplied information doesn’t show that Medpace is cheaper than CON. Medpace’s P/E is 36.2, and its average analyst price target of US$651.31 is below its latest close of US$659.70.
What the CON vs. MEDP headline says
The November 2 headline asks whether CON or Medpace Holdings offers better value. The supplied information doesn’t give CON’s full company name, financial metrics, or the comparison method. It also doesn’t say which stock the article considers the better value.
So this is a third-party comparison headline, not a Medpace corporate announcement or a complete valuation analysis. Medpace’s company-specific figures are available on its stock page, but they don’t provide the missing details about CON.
What Medpace’s supplied numbers show
Medpace’s latest supplied close was US$659.70, and its P/E was 36.2. Its market capitalization was about US$18.24 billion. The supplied figures also show an 18.2% profit margin, 117.9% return on equity, and US$18.01 in trailing-twelve-month EPS.
Shares were up 13.51% year to date and 8.12% over one month, but down 0.59% for the day. Latest volume was 14,512 shares, compared with a 20-day average of 328,446, or 0.60 times that average. Without comparable figures for CON, these numbers can’t show which stock is cheaper.
The supplied average analyst price target was US$651.31, 1.3% below the latest close. The outlook was Hold. See the analyst-ratings page for those details.
What to watch next
The comparison’s key details are missing: CON’s identity and valuation metrics, the measures used to assess value, and the article’s conclusion. Until those are available, the headline alone doesn’t support a claim about which stock offers better value.
Investors can watch for the underlying comparison figures and assess them separately from Medpace’s standalone financial and market data.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
